Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
Kadambi, Vivek
IDRx, Inc
(
P 316
)
FIRST-IN-HUMAN PHASE 1/1B STUDY OF IDRX-42, A NOVEL ORAL TYROSINE KINASE KIT INHIBITOR, IN PARTICIPANTS WITH METASTATIC AND/OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS
Vivek Kadambi
Favorite
Kadera, Brian
UCLA David Geffen School of Medicine
(
P 173
)
DYSREGULATION OF MITOCHONDRIAL DYNAMICS IN WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA PROVIDES A UNIQUE SUSCEPTABILITY TO NOVEL THERAPY
Brian Kadera
Favorite
Kaiser, Isabelle
University Hospital Essen, Pediatrics III, Essen, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Isabelle Kaiser
Favorite
Kalen, Amanda
Free Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, IA
(
P 178
)
HIGH FREQUENCY OF NAPRT-SILENCING IN NEUROBLASTOMA AND RHABDOMYSARCOMA CONFERS SENSITIVITY TO TARGETING OF NAD+ METABOLISM USING NAMPT INHIBITORS
Amanda Kalen
Favorite
Kalisvaart, G.M.
Department of Radiology, Leiden University Medical Center
(
P 109
)
NOVEL CANDIDATE BIOMARKERS FOR FLUORESCENCE IMAGE-GUIDED SURGERY IN GASTROINTESTINAL STROMAL TUMORS
G.M. Kalisvaart
Favorite
Kanaan, Christina
INSTITUT GUSTAVE ROUSSY
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
Christina Kanaan
Favorite
Kanerva, Jukka
Helsinki University Hospital
(
P 042
)
VALUE OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA AT THE EXTREMITIES. REPORT FROM THE EWING 2008 TRIAL
Jukka Kanerva
Favorite
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Jukka Kanerva
Favorite
Kaneva, Kristiyana
Tempus Labs
(
P 039
)
THE GENOMIC AND IMMUNE LANDSCAPE OF OSTEOSARCOMA
Kristiyana Kaneva
Favorite
Kang, Wenjun
University of Chicago
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Wenjun Kang
Favorite
Kaplan, Jason
Ayala Pharmaceuticals
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Jason Kaplan
Favorite
Karachiwala, Hatim
Tom Baker Cancer Center,
(
P 165
)
REAL- WORLD EXPERIENCE OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH RECURRENT BONE TUMOURS (BT): A CANSARCC STUDY
Hatim Karachiwala
Favorite
Karanian, Marie
CENTRE LEON BERARD
(
P 238
)
EXPANDING THE MOLECULAR SPECTRUM OF GIANT CELL TUMORS.
Marie Karanian
Favorite
Karavasilis, Vasilios
University College London Hospital
(
P 271
)
ORAL VINORELBINE IN DESMOID TUMOURS; A SINGLE CENTRE RETROSPECTIVE ANALYSIS
Vasilios Karavasilis
Favorite
Karim, Rooshdiya
Royal Prince Alfred Hospital
(
P 258
)
TO TREAT OR NOT TO TREAT: AN AUDIT OF INITIAL MANAGEMENT OF PATIENTS WITH DESMOID TUMOURS AT A SPECIALISED CENTRE
Rooshdiya Karim
Favorite
Karim, S. Mohammed
Mayo Clinic
(
P 201
)
LOCAL CONTROL AND SURVIVAL OUTCOMES IN PEDIATRIC NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMA: THE MAYO CLINIC EXPERIENCE
S. Mohammed Karim
Favorite
Kasper, Bernd
Mannheim University Medical Center
(
P 220
)
PROMOTING GLOBAL EDUCATION IN THE FIELD OF RETROPERITONEAL SARCOMA: THE FIRST OPEN-ACCESS EDUCATIONAL WEBINAR SERIES BY THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP
Bernd Kasper
Favorite
(
P 264
)
DESMOID AND TRAUMA: REAL INCIDENCE AND MEDICOLEGAL ASPECTS OF CAUSALITY
Bernd Kasper
Favorite
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Bernd Kasper
Favorite
KASRAOUI, INES
INSTITUT GUSTAVE ROUSSY
(
P 217
)
PLANNED MARGINAL (R1) RESECTION IN PRIMARY RETROPERITONEAL SARCOMAS: RETROSPECTIVE SERIES ON 168 PATIENTS FROM A NATIONAL SPECIALIZED REFERRAL CENTER
INES KASRAOUI
Favorite
Kasson, Lucas
Rush University Medical Center
(
P 283
)
HIP ARTHROPLASTY OUTCOMES IN METASTATIC BONE DISEASE
Lucas Kasson
Favorite
Kaths, Moritz
Department of Visceral Surgery, Sarcoma Center, West German Cancer Center, University Duisburg-Essen, Medical School, Essen, Germany
(
P 108
)
NILOTINIB REVISITED: SALVAGE USE IN PATIENTS WITH SEVERE IMATINIB-TOXICITY
Moritz Kaths
Favorite
Kauertz, Katja
University Hospital Essen, Pediatrics III, Essen, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Katja Kauertz
Favorite
Kaur, Sahibjeet
The Life Raft Group
(
P 110
)
PHASE I RESULTS FROM A MULTI-PHASE COMPREHENSIVE GENOMIC SEQUENCING TUMOR STUDY IN GASTROINTESTINAL STROMAL TUMOR PATIENTS
Sahibjeet Kaur
Favorite
Kawachi, Asuka
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Asuka Kawachi
Favorite
Kawai, Akira
National Cancer Center Hospital
(
P 069
)
CLINICOPATHOLOGICAL FEATURES AND TREATMENT PATHWAYS OF SOFT TISSUE SARCOMA BY TISSUE OF ORIGIN
Akira Kawai
Favorite
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Akira Kawai
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Akira Kawai
Favorite
Kazmer, Alexander
Rush University Medical Center
(
P 053
)
PET-CT STAGING AFFECTS TIME TO TREATMENT IN SARCOMA
Alexander Kazmer
Favorite
(
P 062
)
WHAT IS THE CLINICAL IMPACT OF STAGING AND SURVEILLANCE PET-CT SCAN FINDINGS IN PATIENTS WITH BONE AND SOFT TISSUE SARCOMA?
Alexander Kazmer
Favorite
Keedy, Vicki
Vanderbilt University Medical Center
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Vicki Keedy
Favorite
(
P 266
)
EFFICACY OF LIPOSOMAL DOXORUBICIN IN PATIENTS WITH INTRA- AND EXTRA-ABDOMINAL DESMOID FIBROMATOSIS
Vicki Keedy
Favorite
kelany, mohamed
Ain Shams university
(
P 067
)
CLINICAL-EPIDEMIOLOGICAL AND TREATMENT FACTORS IMPACT ON SURVIVAL IN EGYPTIAN PATIENTS WITH HEAD AND NECK SARCOMA: A RETROSPECTIVE CASE-SERIES ANALYSIS
mohamed kelany
Favorite
Kelly, Aidan
Monopar Therapeutics Inc.
(
P 321
)
PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM FOR ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MAXIMUM TOLERATED DOSE/RECOMMENDED PHASE 2 DOSE.
Aidan Kelly
Favorite
Kelly, Ciara
Memorial Sloan Kettering Cancer Center
(
P 134
)
PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA
Ciara Kelly
Favorite
Kelly-Morland, Christian
The Royal Marsden Hospital
(
P 085
)
RADIATION ASSOCIATED ANGIOSARCOMAS OF THE BREAST: MULTIFOCALITY WARRANTS AGGRESSIVE ONCOLOGICAL STRATEGY
Christian Kelly-Morland
Favorite
Kendal, Joseph
University of California, Los Angeles
(
P 015
)
A SIGNAL FINDING STUDY OF NIVOLUMAB AND RELATLIMAB IN ADVANCED CHORDOMA
Joseph Kendal
Favorite
Kendal, Joseph
Department of Orthopaedic Surgery
(
P 142
)
USE OF SMALL MOLECULE STIMULATE OF TYPE-1 INTERFERON GENES (STING) AGONIST IMMUNOTHERAPY FOR CANINE SARCOMA: A CROSS-SPECIES ANALYSIS
Joseph Kendal
Favorite
Kendal, Joseph
University of California, Los Angeles
(
P 243
)
MUTATIONAL ANALYSIS OF PRIMARY AND ADVANCED CHORDOMA TISSUE USING NEXT-GENERATION SEQUENCING
Joseph Kendal
Favorite
(
P 286
)
INDICATIONS AND LONGEVITY OF ENDOPROSTHETIC RECONSTRUCTIONS FOR PATIENTS WITH METASTATIC BONE DISEASE
Joseph Kendal
Favorite
Kennard, Nicole
Dallas Fort Worth Sarcoma Group
(
P 297
)
PREOPERATIVE EMBOLIZATION TO REDUCE THE RISK OF HEMORRHAGE FOR HEMANGIOPERICYTOMA RESECTION
Nicole Kennard
Favorite
Kenny, Colin
University of Iowa
(
P 235
)
ELUCIDATING THE ONCOGENIC EFFECT OF BCOR-ITD IN SARCOMA
Colin Kenny
Favorite
Kent, Paul
FibroFighters Foundation
(
P 018
)
COMPLETE RESPONSE TO MODEST DOSE RADIATION IN OSTEOSARCOMA METASTASIS IN TWO PATIENTS WITH LI-FRAUMENI SYNDROME
Paul Kent
Favorite
(
P 032
)
PLEURAL RELAPSE OF OSTEOSARCOMA AFTER TALC PLEURODESIS
Paul Kent
Favorite
Keohan, Mary Louise
Memorial Sloan Kettering Cancer Center
(
P 134
)
PHASE II STUDY OF RUCAPARIB AND NIVOLUMAB IN PATIENTS WITH LEIOMYOSARCOMA
Mary Louise Keohan
Favorite
Kessler, Lukas
Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen
(
P 176
)
FIBROBLAST ACTIVATION PROTEIN ALPHA AS THERANOSTIC TARGET IN SARCOMA
Lukas Kessler
Favorite
Kfoury, Maria
Gustave Roussy
(
P 060
)
TOWARD A NEW GENOMIC AND CLINICO-PATHOLOGIC CLASSIFICATION OF UTERINE ADENOSARCOMAS
Maria Kfoury
Favorite
Khalilullah, Ibrahim
University of Texas at Dallas
(
P 248
)
RESULTS OF A NEOADJUVANT REGIMEN USING A FIXED DOSE OF ADRIAMYCIN AS AN ELECTRON AFFINIC AGENT WITH 27GY FOLLOWED BY WIDE LOCAL RESECTION OF SOFT TISSUE SARCOMAS
Ibrahim Khalilullah
Favorite
Khanduri, Isha
MD Anderson Cancer Center
(
P 013
)
A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA
Isha Khanduri
Favorite
Khan, Maria
University of Birmingham
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Maria Khan
Favorite
Khan, Misbah
Sarcoma Unit, Royal Marsden Hospital
(
P 218
)
PRIMARY PELVIC SOFT TISSUE SARCOMAS (PELVISARC): OUTCOMES IN A SERIES OF 401 PATIENTS FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Misbah Khan
Favorite
Khanna, Nehal
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Nehal Khanna
Favorite
(
P 09
)
OUTCOMES, PROGNOSTIC FACTORS AND TREATMENT COMPLIANCE IN OSTEOSARCOMA CASES TREATED WITH AN INDIGENOUS, LOW-COST PROTOCOL, OGS-12, IN A TERTIARY CARE CANCER CENTRE IN INDIA
Nehal Khanna
Favorite
Khan, Omar
University of Calgary Cumming School of Medicine
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Omar Khan
Favorite
Khan, Shahnaz
RTI Health Solutions
(
P 260
)
BURDEN OF ILLNESS OF DESMOID TUMORS
Shahnaz Khan
Favorite
Khatami, Marjan
Research Institute of the McGill University Health Center
(
P 030
)
OSTEOSARCOMA PATIENT-DERIVED-XENOGRAFTS A RELEVANT MODEL TO STUDY CHEMOTHERAPEUTIC AND METASTATIC EVENTS
Marjan Khatami
Favorite
Khatami, Marjan
Department of Experimental Surgery, McGill University
(
P 232
)
DECIPHERING METASTASIS MAINTENANCE AND CHEMO RESISTANCE EVENTS IN CIC-DUX4 SARCOMA
Marjan Khatami
Favorite
Khazaei, Niusha
Department of Human Genetics, McGill University
(
P 030
)
OSTEOSARCOMA PATIENT-DERIVED-XENOGRAFTS A RELEVANT MODEL TO STUDY CHEMOTHERAPEUTIC AND METASTATIC EVENTS
Niusha Khazaei
Favorite
(
P 232
)
DECIPHERING METASTASIS MAINTENANCE AND CHEMO RESISTANCE EVENTS IN CIC-DUX4 SARCOMA
Niusha Khazaei
Favorite
Khosroyani, Homma
OHSU Knight Cancer Institute
(
P 121
)
USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES IN PDGFRA-MUTANT GASTROINTESTINAL STROMAL TUMOR
Homma Khosroyani
Favorite
Kilpatrick, Scott
Cleveland Clinic Lerner College of Medicine
(
P 249
)
SARCOMA GENE FUSION BREAKPOINTS: NON-RANDOM EVENT PATTERNS IN SARCOMAS WITH GENE FUSIONS INCLUDING EWING SARCOMA, DSRCT, RHABDOMYOSARCOMA, SYNOVIAL SARCOMA, CCNB3-BCOR, AND CIC-DUX
Scott Kilpatrick
Favorite
Kim, AeRang
Children's National Hospital
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
AeRang Kim
Favorite
Kim, Edward
University of Washington/Fred Hutch Cancer Center
(
P 063
)
A RETROSPECTIVE COHORT ANALYSIS EVALUATING THE NATURAL HISTORY AND CHARACTERISTICS OF ANGIOSARCOMAS OF THE BREAST
Edward Kim
Favorite
Kim, Eugene
Children's Hospital Los Angeles
(
P 037
)
SURVIVAL OUTCOMES AND POST-SURGICAL MORBIDITY BASED ON SURGICAL APPROACH TO PULMONARY METASTASECTOMY IN PATIENTS WITH OSTEOSARCOMA
Eugene Kim
Favorite
Kim, Hangil
The Ohio State University Comprehensive Cancer Center
(
P 200
)
CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF RADIATION-ASSOCIATED SARCOMAS
Hangil Kim
Favorite
(
P 259
)
ASSOCIATION BETWEEN AREA DEPRIVATION INDEX AND INITIAL TREATMENT AMONG PATIENTS WITH DESMOID TUMORS
Hangil Kim
Favorite
Kim, Han-Soo
Seoul National University School of Medicine
(
P 274
)
AMPUTATION IN PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMA: THE EXPERIENCE OF AN EAST ASIAN REFERRAL CENTER
Han-Soo Kim
Favorite
Kim, Hyo Song
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Hyo Song Kim
Favorite
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Hyo Song Kim
Favorite
Kim, Hyunho
St. Vincent's Hospital, The Catholic University of Korea
(
P 153
)
IFOSFAMIDE/ETOPOSIDE/CARBOPLATIN REGIMEN AS A POST DOXORUBICIN TREATMENT IN METASTATIC OR RECURRENT SOFT TISSUE SARCOMA
Hyunho Kim
Favorite
Kim, Jinseob
Seoul National University
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Jinseob Kim
Favorite
Kim, Kyeong Deok
Inha university
(
P 212
)
COMPARISON OF SURGICAL OUTCOMES BETWEEN LEIOMYOSARCOMA OF INFERIOR VENA CAVA AND OTHER LOCATIONS
Kyeong Deok Kim
Favorite
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Kyeong Deok Kim
Favorite
Kim, Min Jung
Seoul Medical Center
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Min Jung Kim
Favorite
Kim, Sang Kyum
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Sang Kyum Kim
Favorite
Kim, Seong-Jin
Medpacto, Inc.
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Seong-Jin Kim
Favorite
Kim, Seung Hyun
Yonsei University College of Medicine
(
P 265
)
DEVELOPMENT OF THERAPEUTIC STRATEGY FOR DESMOID TUMOR WITH NOVEL PATIENT-DERIVED PRECLINICAL MODEL
Seung Hyun Kim
Favorite
Kim, Yongsung
Seoul National University Bundang Hospital
(
P 274
)
AMPUTATION IN PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMA: THE EXPERIENCE OF AN EAST ASIAN REFERRAL CENTER
Yongsung Kim
Favorite
Kinnaman, Michael
Memorial Sloan Kettering Cancer Center
(
P 307
)
ADOLESCENT AND YOUNG ADULT SARCOMA TREATMENT HARMONIZATION: AYA MAP FOR OSTEOSARCOMA
Michael Kinnaman
Favorite
Kirk, Frazer
Gold Coast University Hospital
(
P 299
)
PULMONARY METASTASECTOMY OF OSTEOSARCOMA VIA PNEUMONECTOMY AND MEDIAN STERNOTOMY WITH COMPLETE INTRATHORACIC LIVER MIGRATION: A CASE REPORT
Frazer Kirk
Favorite
Kirton, Laura
University of Birmingham
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Laura Kirton
Favorite
Kishi, Shingo
Nozaki Tokushukai Hospital
(
P 181
)
MITOCHONDRIAL TRANSFER FROM MESENCHYMAL STEM CELSS MEDIATED BY HMGB1 COULD BE INVOLVED IN DRUG RESISTANCE IN OSTEOSARCOMA CELLS.
Shingo Kishi
Favorite
Kita, Syosuke
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Syosuke Kita
Favorite
Klein, Evan
Rush Medical College
(
P 081
)
MISSING DATA IN THE DEVELOPMENT AND EXTERNAL VALIDATION OF MACHINE LEARNING MODELS FOR SURVIVAL PREDICTION IN SARCOMA
Evan Klein
Favorite
(
P 227
)
ASSOCIATION BETWEEN NEUTROPHIL-LYMPHOCYTE RATIO, PLATELET-LYMPHOCYTE RATIO, AND SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Evan Klein
Favorite
Klein, Stefan
Erasmus Medical Center Rotterdam
(
P 044
)
AUTOMATIC SEGMENTATION USING DEEP LEARNING TO DISTINGUISH BETWEEN 9 TYPES OF SOFT-TISSUE TUMORS WITH RADIOMICS
Stefan Klein
Favorite
Klingbeil, Kyle
UCLA Health
(
P 173
)
DYSREGULATION OF MITOCHONDRIAL DYNAMICS IN WELL-DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA PROVIDES A UNIQUE SUSCEPTABILITY TO NOVEL THERAPY
Kyle Klingbeil
Favorite
Klohe, Erika
Director, Companion Diagnostics Oncology Cell Therapy, GSK
(
P 189
)
PROGNOSTIC IMPACT OF NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 EXPRESSION AND HUMAN LEUKOCYTE ANTIGEN SUBTYPES IN METASTATIC SYNOVIAL SARCOMA
Erika Klohe
Favorite
Klug, Lillian
OHSU Knight Cancer Institute
(
P 121
)
USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES IN PDGFRA-MUTANT GASTROINTESTINAL STROMAL TUMOR
Lillian Klug
Favorite
Kneisl, Jeffrey
Atrium Health/Levine Cancer Institute
(
P 261
)
CLINICAL FEATURES AND TREATMENT OUTCOMES OF PATIENTS WITH DESMOID TUMORS: A LARGE SINGLE INSTITUTION RETROSPECTIVE SERIES
Jeffrey Kneisl
Favorite
Knight, James
School of Natural and Environmental Sciences, Newcastle University, UK
(
P 172
)
DEVELOPMENT OF A TARGETED DUAL-MODALITY RADIOIMMUNOCONJUGATE FOR IMAGE GUIDED SARCOMA SURGERY
James Knight
Favorite
Kobayashi, Eisuke
Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Eisuke Kobayashi
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Eisuke Kobayashi
Favorite
Koh, Kyung-Nam
Asan Medical Center Children's Hospital, University of Ulsan College of Medicine
(
P 043
)
A MULTICENTER, OPEN-LABEL, RANDOMIZED, PHASE 2 STUDY OF LENVATINIB IN COMBINATION WITH IFOSFAMIDE AND ETOPOSIDE VERSUS IFOSFAMIDE AND ETOPOSIDE IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY OSTEOSARCOMA
Kyung-Nam Koh
Favorite
Koike, Hiroshi
Nagoya University Hospital
(
P 262
)
CLINICAL RESULTS OF ACTIVE SURVEILLANCE FOR EXTRA ABDOMINAL DESMOID TYPE FIBROMATOSIS
Hiroshi Koike
Favorite
(
P 322
)
PHASE 2 SINGLE-ARM CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AURANOFIN IN ADULT PATIENTS WITH PROGRESSIVE DESMOID
Hiroshi Koike
Favorite
Kojima, Yuki
Department of Medical Oncology, National Cancer Center Hospital
(
P 147
)
ANALYSIS OF INFLAMMATORY BIOMARKERS AS PREDICTORS OF TREATMENT EFFICACY IN SOFT TISSUE SARCOMA TREATED WITH TRABECTEDIN
Yuki Kojima
Favorite
(
P 150
)
CLINICAL CHARACTERISTICS OF PRIMARY CUTANEOUS AND SUBCUTANEOUS EWING SARCOMA FAMILY OF TUMORS
Yuki Kojima
Favorite
Kok, Jessica Sook Ting
National Cancer Centre Singapore
(
P 174
)
ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA CELL LINE MODEL
Jessica Sook Ting Kok
Favorite
Kondratowski, Sebastian
BC Children's Hospital Research Institute
(
P 033
)
REDUCED H3K27ME3 IMMUNOEXPRESSION IN PEDIATRIC OSTEOSARCOMA IS ASSOCIATED WITH POOR RESPONSE TO NEOADJUVENT THERAPY
Sebastian Kondratowski
Favorite
Konev, Andrei
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO)
(
P 158
)
NEOADJUVANT COMBINATION OF DOXORUBICIN, CISPLATIN AND METHOTREXATE IN PATIENTS AGED 24-40 YEARS WITH OSTEOSARCOMA UNDER THE COVERAGE OF HEMODIALYSIS. AMAP2021-7-2. ONGOING TRIAL
Andrei Konev
Favorite
Konieczkowski, David
James Cancer Center / The Ohio State University
(
P 200
)
CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF RADIATION-ASSOCIATED SARCOMAS
David Konieczkowski
Favorite
Kornreich, Laure
Hopital universitaire des Enfants Reine Fabiola
(
P 270
)
ORAL VINORELBINE ACTIVITY FOR PROGRESSIVE DESMOID FIBROMATOSIS TUMOURS IN YOUNG PATIENTS
Laure Kornreich
Favorite
Kosela-Paterczyk, Hanna
Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology
(
P 166
)
SARCOMA BRAIN METASTASES: EXPERIENCE AT A SINGLE INSTITUTION
Hanna Kosela-Paterczyk
Favorite
(
P 168
)
SYSTEMIC INFLAMMATION INDEX (SII) AS INDEPENDENT PREDICTIVE FACTOR IN PATIENTS WITH L-SARCOMA TREATED WITH TRABECTEDIN - ANALYSIS OF REAL-WORLD EVIDENCE FROM A REFERENCE CENTER
Hanna Kosela-Paterczyk
Favorite
Kosir, Urska
University of Oxford
(
P 064
)
A SYSTEMATIC REVIEW OF PATIENT-REPORTED OUTCOMES USED TO MEASURE HEALTH-RELATED QUALITY OF LIFE IN SOFT-TISSUE SARCOMA
Urska Kosir
Favorite
(
P 082
)
PATIENT-REPORTED OUTCOME MEASURES TO MEASURE HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH SOFT-TISSUE SARCOMA: A SYSTEMATIC REVIEW OF MEASUREMENT PROPERTIES OF PATIENT-REPORTED OUTCOMES
Urska Kosir
Favorite
(
P 092
)
THE SARCOMA-SPECIFIC QUALITY OF LIFE STUDY (SARC-QOL): IDENTIFYING KEY DOMAINS OF HEALTH-RELATED QUALITY OF LIFE IN ADULT PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMA
Urska Kosir
Favorite
Kostbade, Karina
Department of Medical Oncology, West German Cancer Center, University Hospital Essen
(
P 176
)
FIBROBLAST ACTIVATION PROTEIN ALPHA AS THERANOSTIC TARGET IN SARCOMA
Karina Kostbade
Favorite
Kou, Baijun
Regeneron Pharmaceuticals
(
P 131
)
MUCIN 16 (CANCER ANTIGEN 125) EXPRESSION IN EPITHELIOID SARCOMA LEADS TO SINGLE-PATIENT STUDY WITH BISPECIFIC T-CELL ENGAGER UBAMATAMAB (MUCIN16-CD3): A BENCH-TO-BEDSIDE EXPERIENCE
Baijun Kou
Favorite
Kozak, Katarzyna
Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma
(
P 169
)
WHAT IS THE MOSTAPPROPRIATE STUDY ENDPOINT FOR PHASE IICLINICAL TRIALS IN SOFT TISSUE SARCOMA? - CHARACTERISTIC OF THE CURRENT LANDSCAPE OF PHASE II TRIALS
Katarzyna Kozak
Favorite
Kozak, Margaret
University of Iowa Hospitals & Clinics
(
P 159
)
NEOADJUVANT INTRATUMORAL HIGH DOSE TALIMOGENE LAHERPAREPVEC (TVEC) WITH CONCURRENT RADIATION IN HIGH-RISK EXTREMITY AND TRUNK SOFT-TISSUE SARCOMAS
Margaret Kozak
Favorite
(
P 160
)
NEOADJUVANT PHARMACOLOGICAL ASCORBATE WITH CONCURRENT RADIATION IN LOCALLY ADVANCED SOFT-TISSUE SARCOMA OF EXTREMITY/TRUNK AND RETROPERITONEUM
Margaret Kozak
Favorite
Krailo, Mark
Children's Oncology Group
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Mark Krailo
Favorite
Krarup-Hansen, Anders
Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital
(
P 120
)
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF PLASMA SMALL EXTRACELLULAR VESICLES PHENOTYPE IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOUR
Anders Krarup-Hansen
Favorite
Kreimer, Sara
Stanford University
(
P 155
)
LATE EVENTS OCCURRING AFTER 5 YEARS IN PEDIATRIC RHABDOMYOSARCOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Sara Kreimer
Favorite
Krishnamurthy, Anuradha
UPMC Hillman Cancer Center, University of Pittsburgh
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Anuradha Krishnamurthy
Favorite
Krishnan, Chandra Kumar
Cancer Institute (WIA)
(
P 017
)
CLINICAL PROGRESSION ON NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EXTREMITY OSTEOSARCOMA
Chandra Kumar Krishnan
Favorite
(
P 093
)
TIME TO TREATMENT INITIATION IN PRIMARY EXTREMITY SARCOMA: AN ANALYSIS OF DATABASE FROM A REGIONAL CANCER CENTRE OF LOW/MIDDLE INCOME COUNTRY
Chandra Kumar Krishnan
Favorite
Kropotova, Yana
University of Miami
(
P 07
)
HETEROGENEITY IN TREATMENT REGIMENS FOR AYA BONE SARCOMAS: A COMPARISON OF OUTCOMES AT A SINGLE SARCOMA CENTER
Yana Kropotova
Favorite
Kruiswijk, Anouk
Leiden University Medical Center
(
P 076
)
FOLLOW-UP AFTER CURATIVE SURGICAL TREATMENT OF SOFT-TISSUE SARCOMAS: PATIENTS RECEIVING MORE OR LESS VISITIS THAN PROTOCOL AND ASSOCIATIONS WITH RECURRENCE
Anouk Kruiswijk
Favorite
(
P 079
)
HEALTH-RELATED QUALITY OF LIFE OF BONE AND SOFT-TISSUE TUMOR PATIENTS AT TIME OF DIAGNOSIS
Anouk Kruiswijk
Favorite
Kruse, Sabrina
German Cancer Research Center
(
P 231
)
COMPREHENSIVE MOLECULAR PROFILING OF FOLLICULAR DENDRITIC CELL SARCOMA
Sabrina Kruse
Favorite
Ku, Eric
Department of Radiation Oncology, University of California Irvine
(
P 199
)
A STUDY OF PRE- AND POST-TREATMENT NEUTROPHIL COUNTS, LYMPHOCYTE COUNTS, AND NEUTROPHIL-TO-LYMPHOCYTE RATIOS IN PATIENTS WITH SOFT TISSUE SARCOMA UNDERGOING RADIOTHERAPY
Eric Ku
Favorite
Kühne, Thomas
University Children´s Hospital Basel, Department of Oncology/ Haematology, Basel, Switzerland
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Thomas Kühne
Favorite
(
P 042
)
VALUE OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA AT THE EXTREMITIES. REPORT FROM THE EWING 2008 TRIAL
Thomas Kühne
Favorite
(
P 148
)
ANALYSIS OF REECUR TRIAL DATA TO EVALUATE POTENTIAL PROGNOSTIC FACTORS IN RECURRENT AND PRIMARY REFRACTORY EWING SARCOMA (RR-ES)
Thomas Kühne
Favorite
Kuhrij, Laurien
Leiden University Medical Center
(
P 076
)
FOLLOW-UP AFTER CURATIVE SURGICAL TREATMENT OF SOFT-TISSUE SARCOMAS: PATIENTS RECEIVING MORE OR LESS VISITIS THAN PROTOCOL AND ASSOCIATIONS WITH RECURRENCE
Laurien Kuhrij
Favorite
Kumar, Amanda
Duke
(
P 034
)
REGIONAL ANESTHESIA IMPROVES METASTASIS FREE SURVIVAL AFTER SURGICAL RESECTION OF BONE SARCOMAS
Amanda Kumar
Favorite
Kumar, Sonia
Humanitas Research Hospital
(
P 057
)
SARCOMA MICROENVIRONMENT CHARACTERIZATION: CLINICOPATHOLOGICAL ANALYSIS OF ONE-HUNDRED TWENTY-SIX CASES
Sonia Kumar
Favorite
(
P 106
)
LAPAROSCOPY IN GASTRIC GIST: RETROSPECTIVE PRE-POST COMPARISON ANALYSIS OF SHORT TERM OUTCOMES ON A CONSECUTIVE SERIES OF 95 CASES FROM A TERTIARY REFERRAL CENTRE
Sonia Kumar
Favorite
Kummar, Shivaani
Oregon Health & Science University
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Shivaani Kummar
Favorite
Kuniyasu, Hiroki
Nara Medical University
(
P 181
)
MITOCHONDRIAL TRANSFER FROM MESENCHYMAL STEM CELSS MEDIATED BY HMGB1 COULD BE INVOLVED IN DRUG RESISTANCE IN OSTEOSARCOMA CELLS.
Hiroki Kuniyasu
Favorite
Kuo, Christopher
Children's Hospital Los Angeles
(
P 037
)
SURVIVAL OUTCOMES AND POST-SURGICAL MORBIDITY BASED ON SURGICAL APPROACH TO PULMONARY METASTASECTOMY IN PATIENTS WITH OSTEOSARCOMA
Christopher Kuo
Favorite
Kuppen, P.J.K.
Department of Surgery, Leiden University Medical Center
(
P 109
)
NOVEL CANDIDATE BIOMARKERS FOR FLUORESCENCE IMAGE-GUIDED SURGERY IN GASTROINTESTINAL STROMAL TUMORS
P.J.K. Kuppen
Favorite
Kurien, Elizabeth
University of Calgary
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Elizabeth Kurien
Favorite
Kwiatkowski, David
Brigham and Women’s Hospital
(
P 167
)
STUDY-END ANALYSIS FROM AMPECT, AN OPEN-LABEL, PHASE 2 REGISTRATION TRIAL OF PATIENTS WITH ADVANCED MALIGNANT PECOMA TREATED WITH nab-SIROLIMUS, SHOWING DURABILITY OF RESPONSE AND LONG-TERM SAFETY
David Kwiatkowski
Favorite
(
P 313
)
A PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 OR TSC2 GENES (PRECISION I)
David Kwiatkowski
Favorite
Kwong, Winghan Jackie
Daiichi Sankyo, Inc.
(
P 066
)
CHARACTERISTICS OF PATIENTS RECEIVING PEXIDARTINIB IN THE REAL-WORLD SETTING: A CROSS-SECTIONAL SURVEY
Winghan Jackie Kwong
Favorite
KYRIAZOGLOU, ANASTASIOS
Attikon University Hospital
(
P 204
)
PERCEPTIONS AND MANAGEMENT PRACTICES OF SARCOMA EXPERTS ABOUT SOFT TISSUE SARCOMA PATIENTS WITH ISOLATED LUNG METASTASES ACROSS EUROPE
ANASTASIOS KYRIAZOGLOU
Favorite
Back to Top
